发明名称 |
Biosynthesis of human milk oligosaccharides in engineered bacteria |
摘要 |
The invention provides compositions and methods for engineering bacteria to produce fucosylated oligosaccharides, and the use thereof in the prevention or treatment of infection. |
申请公布号 |
US9587241(B2) |
申请公布日期 |
2017.03.07 |
申请号 |
US201314033664 |
申请日期 |
2013.09.23 |
申请人 |
Glycosyn LLC |
发明人 |
Merighi Massimo;McCoy John M.;Heidtman Matthew Ian |
分类号 |
C12N1/21;C12P19/18;C12N15/70;C12N9/00;C12N9/10;C12N9/38;C12P19/26;C07H3/06;C07H13/04;C12P19/00 |
主分类号 |
C12N1/21 |
代理机构 |
Mintz Levin Cohn Ferris Glovsky and Popeo, P.C. |
代理人 |
Mintz Levin Cohn Ferris Glovsky and Popeo, P.C. ;Beattie, J.D. Ingrid A. |
主权项 |
1. An isolated E. coli bacterium comprising
(i) a deletion or functional inactivation of an endogenous β-galactosidase gene; (ii) an exogenous functional β-galactosidase gene comprising a detectable level of β-galactosidase activity that is reduced compared to that of a wild-type E. coli bacterium, wherein the level of β-galactosidase activity comprises between 0.05 and 200 units; (iii) an inactivating mutation in a colanic acid synthesis gene; and (iv) an exogenous lactose-accepting fucosyltransferase gene. |
地址 |
Woburn MA US |